Page last updated: 2024-08-24

plerixafor and Symptom Cluster

plerixafor has been researched along with Symptom Cluster in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ben-Shoshan, M; Jfri, A; Litvinov, IV; Merati, N; Popradi, G; Sivachandran, S; Vinh, DC1
Belizaire, R; Chen, YB; Makar, RS; Spitzer, TR; Sykes, DB1

Reviews

1 review(s) available for plerixafor and Symptom Cluster

ArticleYear
Plerixafor on a WHIM - Promise or Fantasy of a New CXCR4 Inhibitor for This Rare, but Important Syndrome?
    Skin therapy letter, 2022, Volume: 27, Issue:2

    Topics: Agammaglobulinemia; Benzylamines; Cyclams; Fantasy; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Neutropenia; Papillomavirus Infections; Primary Immunodeficiency Diseases; Receptors, CXCR4; Syndrome; Warts

2022

Other Studies

1 other study(ies) available for plerixafor and Symptom Cluster

ArticleYear
Difficulties in hematopoietic progenitor cell collection from a patient with TEMPI syndrome and severe iatrogenic iron deficiency.
    Transfusion, 2015, Volume: 55, Issue:9

    Topics: Benzylamines; Cyclams; Cytapheresis; Erythrocytes, Abnormal; Erythropoietin; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Kidney Diseases; Leukocyte Count; Male; Middle Aged; Paraproteinemias; Polycythemia; Syndrome

2015